StonvexLoading…
StonvexStonvexStonvexCore line items from JBGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $498.60M | $547.31M | $604.20M | $605.82M |
Operating Income | $-171.89M | $-176.99M | $-92.00M | $100.25M |
Net Income | $-139.06M | $-143.53M | $-79.98M | $85.37M |
EPS (Diluted) | $-2.09 | $-1.65 | $-0.78 | $0.70 |
Total Assets | $4.39B | $5.02B | $5.52B | $5.90B |
Total Liabilities | $2.72B | $2.79B | $2.83B | $2.71B |
Cash & Equivalents | $75.27M | $145.80M | $164.77M | $241.10M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 67.36M | 84.50M | 94.31M | 114.01M |